HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand
Author(s) -
Catherine McLean,
Janneke van de Wijgert,
Heidi E. Jones,
John M. Karon,
Janet M McNicoll,
Sara Whitehead,
Sarah Braunstein,
Jullapong Achalapong,
Supaporn Chaikummao,
Jordan W. Tappero,
Lauri E. Markowitz,
Peter H. Kilmarx
Publication year - 2010
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328333bf89
Subject(s) - viral load , medicine , placebo , viral shedding , immunology , randomization , crossover study , sex organ , vaginal flora , lentivirus , randomized controlled trial , human immunodeficiency virus (hiv) , young adult , viral disease , vagina , surgery , biology , virus , pathology , alternative medicine , genetics
To evaluate the safety, including impact on genital HIV RNA shedding, of Carraguard vaginal gel in HIV-infected women.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom